--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Pedi QuikCalc 5" developer_entity: "Burlington Pediatrics, PA" bundle_id: "com.burlingtonpeds.pediquikcalc5" app_store_id: "1539994807" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2025-06-26" report_date: "2026-07-30" last_verified: "2026-07-30T00:00:00.000Z" report_version: "5.1.1" total_reviews: 10 overall_rating: 4.4 confidence: "low" confidence_score: 0.05 data_age_days: 33 momentum_velocity: "zombie" intelligence_version: 3 nemesis: "PediSTAT - Pediatric Emergency" competitor_count: 11 tags: ["medical", "paid", "mobile app", "app review", "app analysis", "pediatricians", "family", "medicine"] canonical_url: "https://marlvel.ai/apps/com-burlingtonpeds-pediquikcalc5" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Pedi QuikCalc 5 Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Paid - **Signal**: Rating 4.4 > **TL;DR:** Pedi QuikCalc 5 is a medical app by Burlington Pediatrics, PA, rated 4.4/5 by 10 users, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Pedi QuikCalc 5 is a medical app by Burlington Pediatrics, PA. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.4/5 (10 reviews) | | **Category** | Medical | | **Developer** | Burlington Pediatrics, PA | | **Pricing** | Paid | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 33d | ## Metadata & Market Performance - **Publisher:** Burlington Pediatrics, PA - **Category:** Medical - **Target Audience:** Pediatricians and family medicine practitioners requiring rapid, weight-based clinical calculations. - **Platforms:** iOS - **Version Reviewed:** 5.1.1 - **Report Date:** 2026-07-30 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 1539994807 - **Bundle ID:** com.burlingtonpeds.pediquikcalc5 - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-07-30 ## Executive Snapshot **What it is:** Pedi QuikCalc 5 is a specialized medical calculator for pediatricians and family medicine practitioners on iOS. **Why users hire it:** It removes the cognitive friction of manual weight-based drug dosing and nomogram plotting during high-pressure clinical encounters. ## App DNA (Features & Intent) - **[Standard] Weight-based Dosing Calculator:** Calculates drug dosages and IV fluid rates based on patient weight inputs, establishing category authority. - **[Differentiator] Bilirubin Nomogram Tool:** Plots bilirubin levels against AAP thresholds, justifying the one-time purchase price. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Differentiator] Automatic Formulary Updates:** Pushes updated dosing guidelines automatically, preventing churn from outdated medical data. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. ## Market Position {#market-position} Pedi QuikCalc 5 holds the #13 Paid position in the US Medical category. The app's reliance on a one-time purchase model at $4.99 contrasts with the broader category shift toward subscription-based, frequently updated medical references. ## Monetization Strategy - **Model:** Paid - **Tiers:** One-time purchase at $4.99 - **Price:** iOS: $4.99 - **Analysis:** The $4.99 price point targets professional users seeking a specialized, ad-free clinical utility. ## SWOT Analysis {#swot} **Core Strengths:** - Specialized bilirubin nomogram tool establishes clinical authority - Customizable home screen reduces time-to-task for clinicians - Automatic formulary updates ensure long-term clinical utility **Growth Levers:** - Localized pricing in high-ARPU international markets - Expansion of formulary to include emerging pediatric specialty guidelines - Integration with common electronic health record workflows ## Recent Changes (v2 → v3) {#recent-changes} Pedi QuikCalc 5 has entered a maintenance-only lifecycle, with no updates for over a year, creating a long-term vulnerability against more agile medical reference tools. The app's competitive narrative has shifted from highlighting niche utility to acknowledging the risks of stagnation in a market moving toward subscription-based, frequently updated platforms. **Overall trend**: Declining **Compared at**: 2026-07-30 ### High-impact changes - **[Shifted] Transition to maintenance-only status** (positioning) ### Medium-impact changes - **[Improved] Formalization of clinical differentiators** (features) - **[Added] Emergence of platform-level threats** (swot) ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Pedi QuikCalc 5 vs PediSTAT - Pediatric Emergency - Top Rival - **PediSTAT - Pediatric Emergency** by PediSTAT: Direct competitor providing rapid, weight-based pediatric emergency medication and equipment calculations. - **Pediatric Care** by Skyscape: Offers comprehensive clinical decision support and dosage calculators for pediatric professionals. - **PedsGuide** by PedsGuide: Focuses on quick-reference pediatric clinical guidelines and dosage verification tools. ### Contenders (Strong Challengers) - **MedCalcX** by MedCalc: A broader medical calculator that includes a highly utilized pediatric dosage module. - **Epocrates** by Epocrates, Inc.: Industry-standard clinical reference app that includes pediatric dosing and safety information. - **QxMD Calculate** by QxMD Software Inc.: Widely used clinical calculator platform with extensive pediatric-specific decision support tools. ### Peers (What They Do Better) - **UpToDate** by Wolters Kluwer Health: The primary clinical resource for pediatricians, often used in conjunction with quick-calc tools. - **Merck Manual Professional** by Merck Sharp & Dohme Corp.: Provides authoritative clinical guidance and reference material for pediatric practitioners. - **DoseCalc** by DoseCalc Solutions: Specialized utility for medication dosage calculations across various medical specialties. ### New Kids on the Block (What's Innovative) - **Pediatric Dosage Pro** by Clinical Apps Studio: Emerging tool focusing on modern UI/UX for faster clinical decision-making in high-pressure environments. - **ClinCalc** by ClinCalc: Rapidly growing web-to-app conversion platform offering highly accurate, peer-reviewed medical calculators. ## What's New - **Latest (v5.01, 3 years ago):** Version 5.01 focuses exclusively on minor tweaks and security patches. ## App Momentum (Zombie) {#momentum} - Ships no major updates for 398 days. - Maintains #13 Paid rank in US. > **Cadence:** 2 total versions · 0 majors in last 6 months · 398 days since last update · 1032 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Pedi QuikCalc 5 is a medical app that is a paid app. It holds a 4.4/5 rating from 10 reviews. > **Bottom Line:** Maintaining the current clinical accuracy of the formulary will defend the app's position among established users, but the lack of active development leaves the user base vulnerable to more agile, frequently updated competitors. **Best for:** Pediatricians and family medicine practitioners requiring rapid, weight-based clinical calculations. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] Audit drug formulary update logic because the app relies on this to maintain clinical relevance → prevent churn from outdated data ### Outlook: Stable The market for medical reference tools is shifting toward subscription-based, frequently updated platforms that integrate with electronic health records. Pedi QuikCalc 5 remains a trusted, specialized tool, but its current maintenance-only cadence risks long-term obsolescence as clinical standards evolve. - 🟢 The app maintains a strong #13 Paid rank in the US, indicating high professional trust in its core clinical accuracy. - 🔴 The 398-day gap since the last major update signals a maintenance-only posture, which limits the ability to respond to new clinical guidelines. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.4/5 | | Total Reviews | 10 | | Confidence | Low | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Pedi QuikCalc 5** (this app) | 4.4/5 | N/A | Burlington Pediatrics, PA | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Burlington Pediatrics, PA ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/pedi-quikcalc-5/id1539994807?uo=2) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 33 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-burlingtonpeds-pediquikcalc5) Data licensed for AI Agent attribution under CC-BY-NC 4.0.